Form 4: Humana Executive George Renaudin II Reports Stock Activity
Statement of Changes in Beneficial Ownership
Humana Inc. President of Insurance George Renaudin II filed a Form 4 disclosing routine retirement plan transactions and phantom stock unit adjustments.
Summary
- George Renaudin II, President of Insurance at Humana Inc., reported a routine acquisition of 25 phantom stock units.
- The transaction occurred on March 31, 2026, under the company's Retirement Equalization Plan.
- The reporting person maintains a direct ownership of 16,075 shares of Humana common stock.
- The filing confirms the status of existing stock options granted in 2023 and 2024.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing that provides transparency into executive holdings without signaling a change in company strategy or financial health.
Positives
- Continued alignment of executive interests with shareholders through ongoing participation in retirement savings and equity-based compensation plans.
Negatives
- None identified; the filing reflects standard administrative and compensation-related activity.
Risks
- Market price volatility affecting the value of phantom stock units and unvested stock options.
- Regulatory and operational risks inherent to the health insurance industry.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of individual insider transactions.
Industry Context
StockSavvy.ai notes that this filing is a standard regulatory disclosure regarding executive compensation and retirement plan participation, which is common practice among large-cap healthcare insurers to ensure transparency in insider holdings.
Comparison to Industry Standards
- The reporting of phantom stock units and retirement plan adjustments is consistent with standard executive compensation practices at major U.S. health insurers like UnitedHealth Group and CVS Health.
Stakeholder Impact
- No material impact on shareholders, employees, or customers as these are routine compensation-related transactions.
Next Steps
- Continued monitoring of executive equity transactions for potential shifts in sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/24/2023 | Grant date for 2023 stock options. |
| 02/21/2024 | Grant date for 2024 stock options. |
| 02/28/2026 | Date of record for retirement plan holdings. |
| 03/31/2026 | Date of the reported phantom stock unit transaction. |
| 04/02/2026 | Filing date of the Form 4. |
Keywords
Humana, Form 4, Insider Trading, Executive Compensation, Health Insurance, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.